Tower Research Capital (TRC)’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2K | Buy |
2,707
+1,946
| +256% | +$21.7K | ﹤0.01% | 3395 |
|
|
2025
Q1 | $9.35K | Sell |
761
-379
| -33% | -$4.66K | ﹤0.01% | 3791 |
|
|
2024
Q4 | $12.8K | Sell |
1,140
-63
| -5% | -$705 | ﹤0.01% | 3587 |
|
|
2024
Q3 | $8.39K | Sell |
1,203
-3,208
| -73% | -$22.4K | ﹤0.01% | 3966 |
|
|
2024
Q2 | $33.3K | Buy |
4,411
+648
| +17% | +$4.9K | ﹤0.01% | 3405 |
|
|
2024
Q1 | $49.7K | Buy |
3,763
+3,511
| +1,393% | +$46.3K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $2.6K | Buy |
+252
| New | +$2.6K | ﹤0.01% | 5191 |
|
|
2023
Q3 | – | Sell |
-90
| Closed | -$404 | – | 6129 |
|
|
2023
Q2 | $404 | Sell |
90
-694
| -89% | -$3.12K | ﹤0.01% | 5632 |
|
|
2023
Q1 | $4K | Sell |
784
-4,928
| -86% | -$25.1K | ﹤0.01% | 5095 |
|
|
2022
Q4 | $9K | Buy |
5,712
+752
| +15% | +$1.19K | ﹤0.01% | 4224 |
|
|
2022
Q3 | $19K | Buy |
+4,960
| New | +$19K | ﹤0.01% | 3978 |
|
|
2022
Q2 | – | Sell |
-1,632
| Closed | -$13K | – | 6382 |
|
|
2022
Q1 | $13K | Buy |
1,632
+506
| +45% | +$4.03K | ﹤0.01% | 3988 |
|
|
2021
Q4 | $11K | Buy |
1,126
+569
| +102% | +$5.56K | ﹤0.01% | 4435 |
|
|
2021
Q3 | $9K | Sell |
557
-786
| -59% | -$12.7K | ﹤0.01% | 4453 |
|
|
2021
Q2 | $32K | Buy |
+1,343
| New | +$32K | ﹤0.01% | 3426 |
|